Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 12:05:45 - browse：5387

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Disclosing genetic information: not as worrisome as once feared

hotspot

WSS

The story of mRNA: From a loose idea to a tool that may help curb Covid

Researchers explore possible ties between long Covid, menopause

The explosion of genetic testing requires a new approach

Why we need to separate burnout from moral injury in health care

Pharmacists can make shortage drugs, but at what cost?

Eli Lilly expects to double planned employment in Boston center

explore

Wikipedia

The need-to-know this morning

Is it time to worry about Moderna?

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Why health workers in Gaza are injured or die at high rates

State Dept. review finds Biden bears some blame for Afghanistan failures

Pharmacists can make shortage drugs, but at what cost?

Walensky prepares to leave CDC — and Congress — behind

Solve the antibiotic resistance crisis with preventive drugs

What does generative AI mean for health care? We asked experts

Medicare reduced heart disease by changing how it pays doctors

Sports medicine is finally prioritizing gender equality

Medicare reduced heart disease by changing how it pays doctors

hotspot

Beam Therapeutics to lay off 20% of its staff, re

New guidelines on severe brain injury complicate already difficult decisions

New guidelines on severe brain injury complicate already difficult decisions

The story of mRNA: From a loose idea to a tool that may help curb Covid

Researchers explore possible ties between long Covid, menopause

The battle over the Brookhaven Landfill on Long Island

hotspot

hotspot

hotspot

hotspot